Business Context and Reporting Period
This Form 8-K Current Report was filed by Biote Corp. (Nasdaq: BTMD) on June 5, 2025, with the report date finalized on June 9, 2025. The filing primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel appointments and associated compensation arrangements.
Material Changes
- Board Appointment: The Board appointed Richard R. Barrera as a Class II director effective June 5, 2025, to fill the vacancy left by the resignation of Steven J. Heyer.
- Committee Assignment: Mr. Barrera was appointed to the Nominating and Corporate Governance Committee.
- Independence: The Board determined Mr. Barrera is "independent" under Nasdaq rules.
Compensation, Risks, and Unusual Items
Compensatory Arrangements
Mr. Barrera's compensation package includes:
- Cash Retainer: $50,000 annual base retainer.
- Initial Equity Award: An option to purchase Class A common stock with a grant-date fair value of $337,500, vesting in 36 monthly installments.
- Annual Equity Award: Automatic grants of options with a fair value of $216,000 at each annual stockholder meeting (prorated for the first year), vesting in full within one year.
- Change in Control: All outstanding equity awards vest immediately upon a change in control.
Indemnification
The Company entered into a standard indemnification agreement with Mr. Barrera, requiring the Company to indemnify him to the fullest extent permitted by Delaware law.
Risks and Contingencies
No specific financial risks or contingencies were disclosed in this filing. The document notes that the press release furnished as Exhibit 99.1 is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the resignation details of the prior director, Steven J. Heyer, to understand the context of the vacancy.
- Review the Company's 2022 Equity Incentive Plan to confirm the availability of shares for the new awards.
- Monitor future filings for the specific number of shares underlying the $337,500 and $216,000 equity awards based on the stock price at the time of grant.
- Check for any subsequent filings regarding the press release dated June 9, 2025, for additional context on the appointment.